COL1A2 and lung adenocarcinoma: COL1A2 did not distinguish the survival differences of overall, progression, and post-progression in the whole groups of lung cancer patients (Fig. S7D), However, it did actually accurately and efficiently in early staged lung adenocarcinoma (Fig. S7D).